Nasdaq Coya News Today

Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 974 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Coya Therapeutics to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, profitability, institutional ownership and risk. Volatility & Risk Coya Therapeutics […]

Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 975 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare Coya Therapeutics to related businesses based on the strength of its profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a […]

Coya Therapeutics (NASDAQ:COYA – Get Free Report) and Spero Therapeutics (NASDAQ:SPRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk Coya Therapeutics has a […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 31,700 shares, a growth of 41.5% from the November 30th total of 22,400 shares. Based on an average trading volume of 46,700 shares, the days-to-cover ratio […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 59,300 shares, a growth of 78.6% from the September 30th total of 33,200 shares. Currently, 0.7% of the company’s shares are sold short. […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 33,200 shares, a decrease of 7.0% from the September 15th total of 35,700 shares. Currently, 0.4% of the company’s stock are short sold. […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Equities researchers at Chardan Capital reduced their FY2023 earnings per share (EPS) estimates for shares of Coya Therapeutics in a note issued to investors on Wednesday, August 9th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings of ($1.45) per share for the […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totalling 4,100 shares, an increase of 10.8% from the June 30th total of 3,700 shares. Based on an average trading volume of 143,800 shares, the short-interest ratio […]

Coya Therapeutics’ (NASDAQ:COYA – Get Rating) lock-up period will end on Tuesday, June 27th. Coya Therapeutics had issued 3,050,000 shares in its IPO on December 29th. The total size of the offering was $15,250,000 based on an initial share price of $5.00. Shares of the company owned by major shareholders and company insiders will be […]

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 44,200 shares, an increase of 65.5% from the May 15th total of 26,700 shares. Currently, 0.6% of the company’s shares are short sold. Based […]